| 000 | 01671nam a2200253 a 4500 | ||
|---|---|---|---|
| 001 | vtls000075879 | ||
| 003 | KUKTEM | ||
| 005 | 20251114204541.0 | ||
| 008 | 131106t2012 my da f m 000 0 eng d | ||
| 020 | _aTHE0002196(Local) | ||
| 039 | 9 |
_a201905131716 _byusri _c201311121658 _dnabilah _y201311061235 _znabilah |
|
| 040 | _aUMP | ||
| 090 | _aQD951 .S24 2012 rs Bc. | ||
| 100 | 0 | _aMohammad Safuan Mat Noor | |
| 245 | 1 | 0 |
_aMolecular dynamics simulation of ibuprofen crystal polymorph / _cMohammad Safuan Mat Noor |
| 260 |
_aKuantan, Pahang : _bUMP, _c2012 |
||
| 300 |
_axix, 82 p. : _bill. ; _c30 cm. + _e1 CD-ROM |
||
| 502 | _aProject paper (Bachelor of Chemical Engineering) -- Universiti Malaysia Pahang – 2012 | ||
| 504 | _aBibliography : p. 71-74 | ||
| 520 | 3 | _aIbuprofen (iso-butyl-propanolic acid) is one of the Active Pharmaceutical Ingredients (API) that uses to treat a symptom of rheumatism, arthritis, fever, as an analgesic (pain reliever). This study aims to identify which solvents should affect the polymorph of ibuprofen begins from the crystallization solution. The Molecular Dynamics Simulation and Fourier transform infrared (FTIR) is used to recognize which molecules that form hydrogen bond in the ibuprofen crystal polymorph. The study analysis has shown that the higher hydrogen bond between the atoms will contribute to the ibuprofen crystal polymorph. As the conclusion, only the selected atoms will contribute in the formation of desired crystal polymorph of ibuprofen. | |
| 650 | 0 | _aIbuprofen | |
| 650 | 0 | _aPolymorphism (Crystallography) | |
| 999 |
_aVIRTUA40 _c3954 _d3960 |
||
| 999 | _aVTLSSORT0080*0200*0400*0900*1000*2450*2600*3000*5020*5040*5200*6500*6501*9992 | ||